Evoke Pharma Inc (13)

Browse by Contract Category

Contracts

Non-Employee Director Compensation Policy, as Amended and Restated Effective January 27, 2021 (Filed With SEC on March 11, 2021)
Third Amendment to Standard Office Lease dated December 15, 2020 between the Company and SB Corporate Centre III-IV, LLC (Filed With SEC on March 11, 2021)
Underwriting Agreement, dated January 13, 2021, by and between Evoke Pharma, Inc. and Laidlaw &Company (UK) Ltd (Filed With SEC on January 14, 2021)
3PL Agreement between the Company and Eversana Life Science Services, Inc. dated August 27, 2020 (Filed With SEC on November 10, 2020)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)
Commercial Services Agreement, dated as of January 21, 2020, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on May 12, 2020)
Loan Agreement, dated as of January 21, 2020, between the Company and Eversana Life Sciences Services, LLC (Filed With SEC on May 12, 2020)
Non-Employee Director Compensation Policy, as Amended and Restated, Effective February 28, 2020 (Filed With SEC on May 12, 2020)
Second Amendment to Standard Office Lease dated December 6, 2019 between the Company and SB CorporateCentre III IV, LLC (Filed With SEC on March 12, 2020)
Commercial Services Agreement, dated as of January 5, 2019, between the Company and Novos Growth, LLC.(certain portions of this exhibit have been omitted and are subject to... (Filed With SEC on May 8, 2019)
First Amendment to the Commercial Services Agreement, dated as of February 28, 2019, between the Company and Novos Growth, LLC (Filed With SEC on May 8, 2019)
First Amendment to Standard Office Lease dated September 27, 2018 between the Company and SB Corporate Centre III-IV, LLC (Filed With SEC on March 6, 2019)
Non-Employee Director Compensation Policy, as Amended and Restated Effective February 6, 2019 (Filed With SEC on March 6, 2019)